Maintenance / Service
PRODUCTS
-
TrialScope Disclose is the industry’s most trusted and comprehensive clinical trial disclosure solution. Simplify, centralize, and gain complete control of your entire global disclosure process from trial planning to results submission, ensuring full transparency and regulatory disclosure compliance at every stage.
-
Ensuring the integrity of results and maintaining regulatory compliance are paramount concerns for any lab today, especially with increasingly complex laboratory processes. Cloud-based device management offers several advantages for laboratory equipment monitoring.
-
Gain confidence in your clinical research data with direct data capture (DDC).
-
Guide operators through dynamic workflows from equipment startup to maintenance.
-
The ORCA solution ensures consistent and precise chemical dosing with enhanced service and system automation to handle changing levels of hydrogen sulfide in real-time. This provides superior odor control performance and protects critical water infrastructure.
WHITE PAPERS AND CASE STUDIES
-
A Blueprint For Progress: Southern Africa's First Digital Water Twin
Digital water twins provide a collaborative framework for managing complex river basins through real-time data visualization and predictive modeling. This approach democratizes technical insights, helping stakeholders bridge data gaps and ensure long-term regional water security.
-
The Clinician Gap
Growing patient demand and limited clinical capacity are straining modern care. Assistive technologies help standardize procedures, reduce variability, and enable consistent, high‑quality outcomes.
-
Leading European CDMO For Drug Product Manufacturing
As timelines tighten and regulatory demands grow, discover how a European CDMO delivers integrated solutions from aseptic fill and finish to packaging and release.
-
How A Pharma Company Improved Yield By 1.5% In Just Three Months
A pharma company faced a 4% yield drop and variability at a manufacturing facility. Explore how they leveraged an AI-based platform to unify data, pinpoint inefficiencies, and enhance consistency in yields.
-
3D Scanning System Brings Digital Characters To Life
Explore how advancements in visual effects, driven by high-speed 3D digital capture systems from Pixel Light Effects, are transforming the entertainment industry.
-
Scaling Of Impingement Jets Mixing For LNP Drug Production
Delve into the intricacies of Impingement Jets Mixing (IJM) technology and its pivotal role in the scalable and reproducible production of Lipid Nanoparticles (LNPs) for drug delivery.
-
Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap
As biopharma complexity grows, flexible CDMOs are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
-
Providing Enhanced Manufacturing Data To Contracting Companies
The life sciences sector is projected to reach $220 billion by 2030. Examine the growth of CDMOs and CMOs, emphasizing the need for digitalization to meet client demands and regulatory standards.
-
How A Rare Disease Biotech Replaced Manual Processes With RTSM Software
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
Enhancing Clinical Trial Flexibility
Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.
-
Radiopharmaceutical Therapy: Global Clinical Trial Insights 2024
By downloading this report, readers will uncover the transformative potential of radiopharmaceuticals in cancer therapy and stay ahead in the evolving cancer treatment landscape.
-
Automating Cell Therapy Manufacturing And Enabling Rapid Multi-Site Tech Transfer
Find out how automating cell therapy manufacturing with a flexible platform can improve biological performance, streamline tech transfer, and support regulatory confidence for scalable, multi-site production.
NEWS
-
PriceSpider's API Accelerate Suite Empowers Omnichannel Brands To Customize Ecommerce Shopping Experiences And Analytics1/28/2025
PriceSpider, the leader in shoppable solutions for omnichannel brands, today announced the launch of the PriceSpider API Accelerate Suite. The suite features two powerful new integrations, Custom Commerce and Data Share, designed to simplify workflows, enhance brand-owned data and optimize the path to purchase.
-
Simbe Expands Next-Generation Computer Vision Technology To Transform Retail Execution5/20/2025
Simbe, the global leader in shelf digitization, today announced significant advancements to Simbe Vision™, its AI-powered computer vision (CV) technology, further solidifying the company's position as the retail industry's most advanced in-store intelligence solution.
-
GovSignals Extends AI-Powered Workflow Solution To Government Agencies With Multi-Million Dollar DIU Contract Win, Advances FedRAMP & IL5 Readiness3/18/2025
GovSignals, the first AI platform to automate the full process of finding and bidding on government contracts, announced today its expansion from supporting government contractors to directly serving government agencies.
-
Neochromosome And Opentrons Introduce Automated Antibody Discovery Solution, Enabling Labs To Achieve Rapid, Cost-Effective In-House Development4/29/2025
Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its subsidiary specializing in products unlocked through genome-scale cell engineering, today announced the Opentrons Flex neoSwitch Workstation powered by the Neochromosome neoSwitch platform for in-house antibody discovery.
-
Zymeworks Receives U.S. FDA Fast Track Designation For ZW191, An Frα-Targeting Antibody-Drug Conjugate3/30/2026
Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZW191, an antibody-drug conjugate (ADC) targeting folate receptor-α (FRα), for the treatment of patients with advanced or metastatic platinum-resistant ovarian cancer (PROC).